![]()
BRS6(FM4) - Metabolic–Endocrine Signalling & Adaptive Regulation
(Peripheral Metabolic Signals and Central Adaptive Responses)
Primary Mechanisms
- BRS6-FM4-PM8 — Adipose Endocrine Regulation
- BRS6-FM4-PM9 — Stress-Modulated Appetite & Reward Regulation
Key Constraints
No shared nutritional constraint is newly established for this refocused FM. The previous glucose-pool mapping remains in architectural history pending relevance review.
1. Definition
Coordinates peripheral metabolic–endocrine signalling and stress-responsive central regulation to communicate energy availability, metabolic state and physiological demand.
- Regulates adipose-derived endocrine output, including adipokine secretion and local glucocorticoid responsiveness.
- Integrates metabolic and stress-related hormonal signals with central appetite and reward regulation.
- Supports communication between peripheral metabolic state and central neuroendocrine responses to changing physiological demands.
2. Primary Biological Effects
Context-appropriate endocrine communication and stress-responsive appetite/reward regulation; no universal direction of adipokine change or eating response is assumed.
4. Mechanistic Basis (Integrated FM Narrative)
4.1 Functional Rationale
Coordinates peripheral metabolic–endocrine signalling and stress-responsive central regulation to communicate energy availability, metabolic state and physiological demand.
4.2 Evidence Summary
Human adipose experiments distinguish endocrine synthesis, secretion and local glucocorticoid conversion. Mouse adipocyte-GR experiments support qualified stress-feedback involvement; they do not establish a corresponding human dietary pathway. Central stress-eating evidence is assessed separately in PM9. See the linked PM evidence and source assessments.
4.3 Functional Boundaries
FM1 retains glycaemic–insulin regulation and glucose disposal. FM2 retains systemic HPA-axis rhythm and cortisol timing. FM3 retains autonomic activation and recovery. BRS3 retains inflammatory activation, redox regulation and resolution. This FM does not own whole-body allostasis or resource allocation across the six BRSs. Inflammatory signalling is a possible Cross-BRS relationship rather than the defining function.
5. Connected Mechanisms
- BRS1(FM1) — Monoaminergic Function — Monoaminergic Function
- BRS3(FM1) — Anti-Inflammatory Signalling Tone — Inflammatory Tone Regulation
- BRS4(FM1) — Cellular Bioenergetics — Cellular Bioenergetics
7. Phenome Connections
Historical integrated outcome interpretations are preserved in the architectural history. No new Phenome confidence or outcome relationship is inferred from this scope reconciliation.
8. References
- [1] Mohammad & Thiemermann (2021) — Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
- [2] Torske et al. (2024) — Mindfulness Meditation Modulates Stress-eating and Its Neural Correlates
- [3] Kiecolt-Glaser et al. (2011) — A Randomized Controlled Trial
- [4] Di Girolamo et al. (2022) — Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult
- [5] Marcelli et al. (2025) — Insights Into Shared Mechanisms and Clinical Implications
- [6] Wang et al. (2019) — Path Analysis for a Case-Control Study
- [7] Chang et al. (2021) — Evidence from a Systematic Review with Meta-analysis
- [8] Cazzola et al. (2024) — A Defense Line to Mitigate Inflammation and Oxidative Stress in Adipose Tissue
- [9] Schmidt et al. (2015) — Prebiotic Intake Reduces the Waking Cortisol Response and Alters Emotional Bias in